Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma. [electronic resource]
- Cancer Sep 2017
- 3568-3575 p. digital
Publication Type: Journal Article
1097-0142
10.1002/cncr.30770 doi
Adult Age Factors Aged Antineoplastic Combined Chemotherapy Protocols--administration & dosage Cause of Death Cohort Studies Disease-Free Survival Female Hematopoietic Stem Cell Transplantation--methods Humans Immunosuppressive Agents--therapeutic use Male Middle Aged Multiple Myeloma--drug therapy Multivariate Analysis Prognosis Proteasome Inhibitors--therapeutic use Remission Induction Retrospective Studies Risk Assessment Sex Factors Survival Analysis Transplantation, Autologous Treatment Failure Treatment Outcome United States